Manulife (Manufacturers Life Insurance)’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $886K | Buy |
44,151
+31,257
| +242% | +$627K | ﹤0.01% | 1879 |
|
|
2025
Q1 | $254K | Sell |
12,894
-3,942
| -23% | -$77.6K | ﹤0.01% | 2395 |
|
|
2024
Q4 | $379K | Sell |
16,836
-446
| -3% | -$10K | ﹤0.01% | 2360 |
|
|
2024
Q3 | $441K | Buy |
17,282
+3,518
| +26% | +$89.9K | ﹤0.01% | 2335 |
|
|
2024
Q2 | $322K | Buy |
+13,764
| New | +$322K | ﹤0.01% | 2390 |
|
|
2024
Q1 | – | Sell |
-10,095
| Closed | -$140K | – | 2959 |
|
|
2023
Q4 | $140K | Buy |
+10,095
| New | +$140K | ﹤0.01% | 2729 |
|